These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1162 related articles for article (PubMed ID: 7203712)
1. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera. Schneider MU; Troye M; Paulie S; Perlmann P Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712 [TBL] [Abstract][Full Text] [Related]
2. Plasma membrane-associated antigens on tumor cells derived from transitional-cell carcinoma of the human urinary bladder. II. Identification at the molecular level of plasma membrane-associated antigens. Schneider MU; Paulie S; Troye M; Perlmann P Int J Cancer; 1980 Aug; 26(2):193-202. PubMed ID: 7203713 [TBL] [Abstract][Full Text] [Related]
3. Lymphocyte-mediated lysis of tumor cells in vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls. Troye M; Hansson Y; Paulie S; Perlmann P; Blomgren H; Johansson B Int J Cancer; 1980 Jan; 25(1):45-51. PubMed ID: 7399744 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures. Troye M; Vilien M; Pape GR; Perlmann P Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743 [TBL] [Abstract][Full Text] [Related]
5. K cell mediated lysis of cultured colon carcinoma and urinary bladder carcinoma cells induced by monospecific antisera against carcinoembryonic antigen (CEA) and two CEA-related normal glycoproteins. Hammarström S; Troye M; Wahlund G; Svenberg T; Perlmann P Int J Cancer; 1977 Jun; 19(6):756-66. PubMed ID: 873641 [TBL] [Abstract][Full Text] [Related]
6. Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma. Correlation between direct and antibody-dependent cell-mediated cytotoxicity. Hansson Y; Paulie S; Larsson A; Lundblad ML; Perlmann P; Näslund I Cancer Immunol Immunother; 1983; 16(1):23-9. PubMed ID: 6556949 [TBL] [Abstract][Full Text] [Related]
7. HLA antigen expression on urothelial cells: detection by antibody-dependent cell-mediated cytotoxicity. O'Toole CM; Tiptaft RC; Stevens A Int J Cancer; 1982 Apr; 29(4):391-5. PubMed ID: 7085129 [TBL] [Abstract][Full Text] [Related]
8. Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines. Paulie S; Hansson Y; Lundblad ML; Perlmann P Int J Cancer; 1983 Mar; 31(3):297-303. PubMed ID: 6826254 [TBL] [Abstract][Full Text] [Related]
9. Antigen(s) on human transitional cell carcinoma detected by a xenogeneic antiserum. Bloom ET Urol Res; 1977; 5(3):141-8. PubMed ID: 919114 [TBL] [Abstract][Full Text] [Related]
10. Production of antibodies to cellular antigens by EBV-transformed lymphocytes from patients with urinary bladder carcinoma. Paulie S; Lundblad ML; Hansson Y; Koho H; Ben-Aissa H; Perlmann P Scand J Immunol; 1984 Nov; 20(5):461-70. PubMed ID: 6095441 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. II. Identification of the cellular target structures by immunoprecipitation and SDS-PAGE analysis. Paulie S; Koho H; Ben-Aissa H; Hansson Y; Lundblad ML; Perlmann P Cancer Immunol Immunother; 1984; 17(3):173-9. PubMed ID: 6383601 [TBL] [Abstract][Full Text] [Related]
12. Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder. Ben-Aissa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Lundblad ML; Gustafson H; Jonsdottir I; Perlmann P Br J Cancer; 1985 Jul; 52(1):65-72. PubMed ID: 4015953 [TBL] [Abstract][Full Text] [Related]
13. Immunological characterization of cell lines establishing from malignant and normal human urothelium. Vilien M; Wolf H; Rasmussen F Eur J Cancer (1965); 1981 Mar; 17(3):321-7. PubMed ID: 7262169 [No Abstract] [Full Text] [Related]
14. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium. Summerhayes IC; McIlhinney RA; Ponder BA; Shearer RJ; Pocock RD J Natl Cancer Inst; 1985 Dec; 75(6):1025-38. PubMed ID: 2415743 [TBL] [Abstract][Full Text] [Related]
15. Detection of antigens on transitional cell carcinoma with a xenogeneic antiserum. Bloom ET Natl Cancer Inst Monogr; 1978 Dec; (49):57-8. PubMed ID: 86168 [TBL] [Abstract][Full Text] [Related]
16. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium. Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746 [TBL] [Abstract][Full Text] [Related]
17. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary. Perlmann P; Troye M; Pape G; Blomgren H; Johansson B Urol Res; 1978; 6(4):207-9. PubMed ID: 741533 [TBL] [Abstract][Full Text] [Related]
18. Identification of "tumor-associated" nucleolar antigens in human urothelial cancer. Yu D; Pietro T; Jurco S; Scardino PT J Urol; 1987 Sep; 138(3):636-9. PubMed ID: 3305995 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence. Koho H; Paulie S; Ben-Aissa H; Jónsdóttir I; Hansson Y; Lundblad ML; Perlmann P Cancer Immunol Immunother; 1984; 17(3):165-72. PubMed ID: 6383600 [TBL] [Abstract][Full Text] [Related]
20. Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators. Moroz C; Madgar I; Twig S; Lindner A; Many M Int J Cancer; 1982 Jun; 29(6):667-72. PubMed ID: 6980847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]